10x Genomics, Inc.
TXG
$20.92
$0.422.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.26% | 5.25% | 1.92% | 2.02% | -0.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.26% | 5.25% | 1.92% | 2.02% | -0.13% |
| Cost of Revenue | -2.01% | 1.24% | -5.00% | -12.02% | -10.69% |
| Gross Profit | 4.24% | 7.14% | 5.38% | 9.67% | 5.66% |
| SG&A Expenses | -17.41% | -9.36% | -2.51% | -0.64% | 0.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.12% | -7.36% | -3.84% | -3.94% | -3.30% |
| Operating Income | 61.89% | 47.60% | 24.40% | 23.90% | 12.87% |
| Income Before Tax | 87.45% | 77.54% | 58.45% | 65.99% | 40.29% |
| Income Tax Expenses | -6.19% | -26.18% | -51.36% | -19.60% | -50.83% |
| Earnings from Continuing Operations | 85.57% | 76.16% | 58.19% | 64.72% | 40.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 85.57% | 76.16% | 58.19% | 64.72% | 40.58% |
| EBIT | 61.89% | 47.60% | 24.40% | 23.90% | 12.87% |
| EBITDA | 78.98% | 58.80% | 29.44% | 27.35% | 13.70% |
| EPS Basic | 86.67% | 77.07% | 59.18% | 65.33% | 42.17% |
| Normalized Basic EPS | 70.71% | 56.01% | 27.05% | 28.36% | 16.21% |
| EPS Diluted | 86.71% | 77.13% | 59.30% | 65.41% | 41.98% |
| Normalized Diluted EPS | 70.70% | 56.00% | 27.03% | 28.35% | 16.21% |
| Average Basic Shares Outstanding | 4.05% | 3.56% | 3.07% | 2.72% | 2.67% |
| Average Diluted Shares Outstanding | 4.20% | 3.72% | 3.23% | 2.88% | 2.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |